These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1281041)

  • 1. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Okamura J; Ogawa M; Ohashi Y; Tani M; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S1-6. PubMed ID: 1281041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison between L-TAE with farmorubicin and L-TAE with adriamycin: preliminary results (second cooperative study). Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S97-102. PubMed ID: 7511070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective and randomized trial of lipiodol-transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Kawai S; Tani M; Okamura J; Ogawa M; Ohashi Y; Monden M; Hayashi S; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C; Sakata Y; Shimamura Y; Jinno K; Takahashi A; Takayasu K; Tamura K; Nagasue N; Nakanishi Y; Makino M; Masuzawa M; Yumoto Y; Mori T; Oda T
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-38-S6-45. PubMed ID: 9151915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of L-TAE with Farmorubicin and L-TAE with adriamycin (second cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan.
    Okamura J; Kawai S; Ogawa M; Ohashi Y; Tani M; Inoue J; Kawarada Y; Kusano M; Kubo Y; Kuroda C
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S20-4. PubMed ID: 1333903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma.
    Aoyama K; Tsukishiro T; Okada K; Tsuchida T; Aiba N; Nambu S; Miyabayashi C; Yasuyama T; Higuchi K; Watanabe A
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S55-9. PubMed ID: 1281046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinostatin stimalamer-transcatheter arterial embolization for hepatocellular carcinoma: a comparison with lipiodol-transcatheter arterial embolization.
    Hirashima N; Sakakibara K; Itazu I; Hirai T; Nemoto A; Matsuura H; Kumada K; Nojiri O; Kano H
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-91-S6-96. PubMed ID: 9151922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of chemoembolization therapy for primary liver cancer using a stabilized adriamycin-lipiodol suspension.
    Horiguchi Y; Itoh M; Takagawa H; Imai H; Kamei A; Sekoguchi B; Nagamura Y
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S60-4. PubMed ID: 1333909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipiodol transcatheter arterial chemoembolization for non-resectable hepatocellular carcinoma--multicenter cooperative study].
    Kawai S; Tani M; Mikuriya S; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Jinno K; Makino M; Oda T
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):227-32. PubMed ID: 2154160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
    Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Nakamura H; Kuroda C; Fujita M; Yoshioka H
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S72-6. PubMed ID: 1333913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of preoperative transcatheter arterial embolization in the treatment of resectable primary liver cancer.
    Nagasue N; Kohno H; Uchida M
    Semin Surg Oncol; 1993; 9(4):327-31. PubMed ID: 8210914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area.
    Watanabe S; Nishioka M; Ohta Y; Ogawa N; Ito S; Yamamoto Y
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S93-6. PubMed ID: 8137492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasms.
    Hashimoto N; Kawai S; Mikuriya S; Oda T; Inoue J; Shimamura Y; Takahashi A; Masuzawa M; Yumoto Y; Makino M
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S21-5. PubMed ID: 2466582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
    Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma.
    Chen MS; Li JQ; Zhang YQ; Lu LX; Zhang WZ; Yuan YF; Guo YP; Lin XJ; Li GH
    World J Gastroenterol; 2002 Feb; 8(1):74-8. PubMed ID: 11833075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresectable hepatocellular carcinoma in cirrhosis: survival, prognostic factors, and unexpected side effects after transcatheter arterial chemoembolization.
    Farinati F; De Maria N; Marafin C; Herszènyi L; Del Prato S; Rinaldi M; Perini L; Cardin R; Naccarato R
    Dig Dis Sci; 1996 Dec; 41(12):2332-9. PubMed ID: 9011438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma.
    Ohishi H; Yoshimura H; Uchida H; Sakaguchi H; Yoshioka T; Ohue S; Matsui T; Takaya A; Tsujii T
    Cancer Chemother Pharmacol; 1989; 23 Suppl():S33-6. PubMed ID: 2538263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraisal of combination treatment for hepatocellular carcinoma: long-term follow-up and lipiodol-percutaneous ethanol injection therapy.
    Tateishi H; Oi H; Masuda N; Yano H; Matsui S; Kinuta M; Maruyama H; Yayoi E; Okamura J
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-81-S6-90. PubMed ID: 9151921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
    Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of transcatheter arterial embolization (TAE) for large hepatocellular carcinoma using a lecithin-added Lipiodol emulsion].
    Kobayashi S; Otsubo T; Koizumi S; Yoshitoshi K; Katagiri S; Furukawa T; Yamamoto M; Takasaki K
    Nihon Shokakibyo Gakkai Zasshi; 2007 Nov; 104(11):1601-6. PubMed ID: 17984608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma.
    Yumoto Y; Jinno K; Tokuyama K; Wada T; Kobashi H; Okamoto T; Toki H; Inatsuki S; Hara K; Moriwaki S
    Int J Hyperthermia; 1991; 7(1):7-17. PubMed ID: 1711090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.